These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 18541718)

  • 21. Longitudinal analysis of T-cell receptor variable beta chain repertoire in patients with acute graft-versus-host disease after allogeneic stem cell transplantation.
    Liu C; He M; Rooney B; Kepler TB; Chao NJ
    Biol Blood Marrow Transplant; 2006 Mar; 12(3):335-45. PubMed ID: 16503503
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ex vivo fludarabine exposure inhibits graft-versus-host activity of allogeneic T cells while preserving graft-versus-leukemia effects.
    Giver CR; Montes RO; Mittelstaedt S; Li JM; Jaye DL; Lonial S; Boyer MW; Waller EK
    Biol Blood Marrow Transplant; 2003 Oct; 9(10):616-32. PubMed ID: 14569558
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [An anti-human ovarian carcinoma and CD3 bispecific single-chain antibody mediates CDR3 spectratype drift of T cell receptor alpha and beta chains].
    Luo W; Wen Q; Zhou M; Ma L
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Jun; 32(7):919-23. PubMed ID: 22820567
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Organ-specific T cell receptor repertoire in target organs of murine graft-versus-host after transplantation across minor histocompatibility antigen barriers.
    Schilbach K; Schick J; Fluhr H; Marquordt K; Wehrmann M; Schütt BS; Schlegel PG; Niethammer D; Eyrich M
    Transplantation; 2004 Jul; 78(1):31-40. PubMed ID: 15257036
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [CDR3 spectratyping and clonal expansion of peripheral blood T cells in a patient with beta-mediterranean anaemia following peripheral blood stem cell transplantation].
    Yao XS; Zhou MQ; Ma L; Luo W; Feng XQ; Wen Q; Wang XN
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Apr; 28(4):529-32. PubMed ID: 18495582
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The molecular characteristics of T-cell immune reconstitution in leukemia patients after allogeneic hematopoietic stem cell transplantation].
    Fu YW; Wu DP; Sun AN; Feng YF; Chang WR; Zhu ZL; Zhu P
    Zhonghua Xue Ye Xue Za Zhi; 2007 May; 28(5):312-7. PubMed ID: 17877159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Specific donor Vbeta-associated CD4 T-cell responses correlate with severe acute graft-versus-host disease directed to multiple minor histocompatibility antigens.
    Jones SC; Friedman TM; Murphy GF; Korngold R
    Biol Blood Marrow Transplant; 2004 Feb; 10(2):91-105. PubMed ID: 14750075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Donor lymphocyte infusion: the use of alloreactive and tumor-reactive lymphocytes for immunotherapy of malignant and nonmalignant diseases in conjunction with allogeneic stem cell transplantation.
    Slavin S; Morecki S; Weiss L; Or R
    J Hematother Stem Cell Res; 2002 Apr; 11(2):265-76. PubMed ID: 11983098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endogenous superantigens in allogeneic bone marrow transplant recipients rapidly and selectively expand donor T cells which can produce IFN-gamma.
    Jones MS; Riley R; Hamilton BL; Paupe J; Perez D; Levy RB
    Bone Marrow Transplant; 1994 Nov; 14(5):725-35. PubMed ID: 7889005
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Longitudinal monitoring of immune reconstitution by CDR3 size spectratyping after T-cell-depleted allogeneic bone marrow transplant and the effect of donor lymphocyte infusions on T-cell repertoire.
    Verfuerth S; Peggs K; Vyas P; Barnett L; O'Reilly RJ; Mackinnon S
    Blood; 2000 Jun; 95(12):3990-5. PubMed ID: 10845939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Flt3-L augments the engraftment of donor-derived bone marrow cells when combined with sublethal irradiation and costimulatory (CD28/B7 and CD40/CD40L) blockade.
    Woodward JE; Salam A; Logar AJ; Schaefer AT; Rao AS
    Cell Transplant; 2002; 11(2):147-59. PubMed ID: 12099638
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular analysis of T-cell repertoire in patients with graft-versus-host disease after allogeneic stem cell transplantation.
    Tsutsumi Y; Tanaka J; Miura Y; Toubai T; Kato N; Fujisaw F; Toyoshima N; Ota S; Mori A; Yonezumi M; Chiba K; Kondo T; Hasino S; Kobayasi R; Masauji N; Kasai M; Asaka M; Imamura M
    Leuk Lymphoma; 2004 Mar; 45(3):481-8. PubMed ID: 15160909
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of T cell repertoire in patients with graft-versus-leukemia after donor lymphocyte infusion.
    Claret EJ; Alyea EP; Orsini E; Pickett CC; Collins H; Wang Y; Neuberg D; Soiffer RJ; Ritz J
    J Clin Invest; 1997 Aug; 100(4):855-66. PubMed ID: 9259585
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toxicity and efficacy of defined doses of CD4(+) donor lymphocytes for treatment of relapse after allogeneic bone marrow transplant.
    Alyea EP; Soiffer RJ; Canning C; Neuberg D; Schlossman R; Pickett C; Collins H; Wang Y; Anderson KC; Ritz J
    Blood; 1998 May; 91(10):3671-80. PubMed ID: 9573003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distinct oligoclonal T cells are associated with graft versus host disease after stem-cell transplantation.
    Berrie JL; Kmieciak M; Sabo RT; Roberts CH; Idowu MO; Mallory K; Chung HM; McCarty JM; Borrelli CA; Detwiler MM; Kazim AL; Toor AA; Manjili MH
    Transplantation; 2012 May; 93(9):949-57. PubMed ID: 22377792
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Administration of interleukin-7 after allogeneic bone marrow transplantation improves immune reconstitution without aggravating graft-versus-host disease.
    Alpdogan O; Schmaltz C; Muriglan SJ; Kappel BJ; Perales MA; Rotolo JA; Halm JA; Rich BE; van den Brink MR
    Blood; 2001 Oct; 98(7):2256-65. PubMed ID: 11568014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Delayed infusion of immunocompetent donor cells after bone marrow transplantation breaks graft-host tolerance allows for persistent antileukemic reactivity without severe graft-versus-host disease.
    Johnson BD; Truitt RL
    Blood; 1995 Jun; 85(11):3302-12. PubMed ID: 7756664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. T Cell Repertoire Evolution after Allogeneic Bone Marrow Transplantation: An Organizational Perspective.
    Meier JA; Haque M; Fawaz M; Abdeen H; Coffey D; Towlerton A; Abdeen A; Toor A; Warren E; Reed J; Kanakry CG; Keating A; Luznik L; Toor AA
    Biol Blood Marrow Transplant; 2019 May; 25(5):868-882. PubMed ID: 30677510
    [TBL] [Abstract][Full Text] [Related]  

  • 40. T-Cell recovery in adults and children following umbilical cord blood transplantation.
    Klein AK; Patel DD; Gooding ME; Sempowski GD; Chen BJ; Liu C; Kurtzberg J; Haynes BF; Chao NJ
    Biol Blood Marrow Transplant; 2001; 7(8):454-66. PubMed ID: 11569891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.